Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yoshimi Johnson"'
Autor:
Amit S. Adhikari, Juliete Macauley, Yoshimi Johnson, Mike Connolly, Timothy Coleman, Teri Heiland
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer with a median survival of 15 months that has remained unchanged despite advances in the standard of care. GBM cells express human cytomegalovirus (HCMV) proteins, providing a unique
Externí odkaz:
https://doaj.org/article/6032ad8fb27449e4b255a8ac775069d1
Autor:
Alex Cazes, Krista Kinneer, Bilal Omar, Jon Chesebrough, Judith Anderton, Jixin Wang, Anna D. Staniszewska, Steven Arbitman, Kalyani Daita, Himanshi Desai, Yoshimi Johnson, Raymond Rothstein, Marco Gymnopoulos, Giulia Fabbri, Zachary A. Cooper, Mark Albertella, Scott A. Hammond, Sabina Cosulich, Nadia Luheshi, Puja Sapra
Publikováno v:
Cancer Research. 83:2947-2947
B7-H4 is a cell-surface protein overexpressed in several tumor types and is most prevalent in triple-negative breast (TNBC) cancer (74%), ovarian carcinoma (77%), endometrial carcinoma (94%), and cholangiocarcinoma (89%). In contrast, it has a limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7606466bf8f80b20b945b18e935f465b
https://doi.org/10.1158/1538-7445.am2023-2947
https://doi.org/10.1158/1538-7445.am2023-2947
Autor:
Yoshimi Johnson, Amit Adhikari, Greg Wilson, Juliete Macauley, Anthony Marketon, Teri Heiland, Barb Toll
Publikováno v:
Neuro Oncol
Glioblastoma (GBM) is an aggressive form of brain cancer with a median survival of 15 months, remaining unchanged in spite of technological advances in the standard of care. The presence of the partial CMV genome, specifically in GBM cells, provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d849988fefb61d828e0b757710e66313
https://europepmc.org/articles/PMC6847976/
https://europepmc.org/articles/PMC6847976/
Publikováno v:
Journal of Clinical Oncology. 39:e14565-e14565
e14565 Background: Glioblastoma (GBM) is an aggressive form of brain cancer with a median survival of 15 months which has remained unchanged despite technological advances in the standard of care. GBM cells specifically express human cytomegalovirus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f389217abe89513470b9a26f86a37c6d
https://doi.org/10.1200/jco.2021.39.15_suppl.e14565
https://doi.org/10.1200/jco.2021.39.15_suppl.e14565